TWC
GENB

TD Waterhouse Canada’s Generate Biomedicines GENB Stock Holding History

TD Waterhouse Canada’s Portfolio GENB Stock Details GENB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.46K Buy
+573
New +$7.81K ﹤0.01% 1836

Other funds holding GENB

MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

TD Waterhouse Canada's GENB Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Generate Biomedicines (GENB) in Q2 2026: 573 shares worth $9.46K. The stake represents ﹤0.01% of the portfolio and ranks #1836 among its holdings.

4 funds tracked by Wall St. Rank hold GENB as of Q2 2026.

  • TD Waterhouse Canada held 573 shares of Generate Biomedicines worth $9.46K as of Q2 2026.
  • Generate Biomedicines was a new TD Waterhouse Canada position in Q2 2026.
  • Generate Biomedicines made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1836 holding.
  • 4 funds tracked by Wall St. Rank held Generate Biomedicines as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.